Discover
OPRX
OptimizeRx Corporation
6.08
2 x 4.35
2 x 7.39
bid
ask
+
0.36
6.29%
2 @ 06:01 AM
6.13 +0.05 (0.82%)
| Ytd | -50.41% | |
| 1y | -55.26% |
5.78
day range
6.15
4.54
52 week range
22.25
| Open | 5.80 | Prev Close | 5.72 | Low | 5.78 | High | 6.15 | Mkt Cap | 114.09M |
| Vol | 595.23K | Avg Vol | 482.56K | EPS | 0.36 | P/E | 16.89 | Forward P/E | 9.86 |
| Beta | 1.32 | Short Ratio | 2.70 | Inst. Own | 68.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 5.55 | 200-d Avg | 11.00 | 1yr Est | 10.36 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | 0.06 | 0.12 | 0.06 | 100.00% |
| 2024-08-08 | 2024-06 | -0.07 | 0.02 | 0.09 | 128.57% |
| 2024-05-14 | 2024-03 | -0.11 | -0.11 | N/A | N/A |
| 2024-04-16 | 2023-12 | 0 | 0.26 | N/A | N/A |
| 2023-11-06 | 2023-09 | 0.02 | 0.09 | 0.07 | 350.00% |
| 2023-08-14 | 2023-06 | -0.02 | -0.01 | 0.01 | 50.00% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-20 | Stephens & Co. | Upgrade | Equal-Weight | |
| 2024-11-14 | RBC Capital | Upgrade | Outperform | Outperform |
| 2024-11-14 | Roth MKM | Upgrade | Buy | Buy |
| 2024-11-14 | Stifel | Upgrade | Buy | Buy |
| 2024-11-14 | Barclays | Upgrade | Equal-Weight | Equal-Weight |
| 2024-11-14 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
Profile
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-12-18 | BESCH DOUG | Officer | 11.58K | Conversion of Exercise of derivative security |
| 2024-12-11 | FEBBO WILLIAM J | Chief Executive Officer | 601.25K | Purchase |
| 2024-06-06 | KLEMA CATHERINE M | Director | 6.64K | Stock Award(Grant) |
| 2024-06-06 | LANG JAMES PAUL | Director | 68.04K | Stock Award(Grant) |
| 2024-12-18 | ODENCE-FORD MARION K. | General Counsel | 27.23K | Conversion of Exercise of derivative security |
| 2024-12-18 | SILVESTRO STEPHEN L | Officer | 80.85K | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | First Light Asset Management, LLC | 1.81M | 8.75M | 14.98% |
| 2024-09-29 | Blackrock Inc. | 1.27M | 6.16M | 10.54% |
| 2024-09-29 | AWM Investment Company, Inc. | 1.07M | 5.18M | 8.86% |
| 2024-09-29 | Samjo Management, LLC | 1.04M | 5.05M | 8.64% |
| 2024-09-29 | Vanguard Group Inc | 952.89K | 4.60M | 7.88% |
| 2024-09-29 | Blair (William) & Company, L.L.C. | 677.09K | 3.27M | 5.60% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 506.69K | 2.45M | 4.19% |
| 2024-10-30 | iShares Russell 2000 ETF | 453.85K | 2.19M | 3.75% |
| 2024-10-30 | Jacob Internet Fund | 278.27K | 1.34M | 2.30% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 270.27K | 1.31M | 2.23% |
| 2024-08-30 | Fidelity Small Cap Index Fund | 182.43K | 881.15K | 1.51% |
| 2024-10-30 | iShares Russell 2000 Growth ETF | 156.03K | 753.62K | 1.29% |
Split
| Split | Date |
|---|---|
| 1 : 3 | 2018-05-14 |
| 0.001 : 1 | 2008-04-02 |